Oramed Pharmaceuticals Accrued Expenses (Quarterly) Analysis

Oramed Pharmaceuticals, Inc. (ORMP)

3.46 -0.27 (-7.24%) USD | NASDAQ | Feb 26, 12:04

View Accrued Expenses (Quarterly) for ORMP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Accrued Expenses (Quarterly) Benchmarks

Start Trial